Leucine-rich α2-glycoprotein (LRG), an inflammation-induced glycoprotein produced by neutrophils and intestinal epithelial cells, has recently emerged as a promising biomarker in IBD, showing closer correlation with mucosal inflammation than C-reactive protein (CRP) [14,15]. This evidence concerns the gene CRP and inflammatory bowel disease.